Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.
Seamless Therapeutics has raised $12.6M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Seamless Therapeutics's investors include Forbion Capital Partners, Wellington Partners, GO-Bio.
Seamless Therapeutics is headquartered in Dresden, Germany.
Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.
Seamless Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seamless Therapeutics — Funding & Investors." VCBacked, April 23, 2024, https://www.vcbacked.co/company/seamless-therapeutics. Accessed August 13, 2026.
VCBacked. (2024). Seamless Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/seamless-therapeutics
{{cite web |title=Seamless Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/seamless-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated